Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Fate and effects of cytostatic pharmaceuticals in the environment and the identification of biomarkers for and improved risk assessment on environmental exposure
Authors:ID Filipič, Metka (Author)
Files:.pdf PDF - Presentation file, download (226,50 KB)
MD5: 7B3348B30EC8D7CC9A016B341CBEEF42
 
URL URL - Source URL, visit https://cordis.europa.eu/project/id/265264/reporting
 
Language:English
Typology:2.13 - Treatise, Preliminary Study, Study
Organization:Logo NIB - National Institute of Biology
Abstract:CytoThreat (www.cytothreat.eu) project addresses the needs of the European society for assessing the risks associated with the release of pharmaceuticals into environment focusing on cytostatic pharmaceuticals. The mechanisms of action of most of the anticancer drugs are by interference with genetic material and cell signalling, which are very similar in all organisms and theoretically exposure to anticancer drug residues may affect also nontarget organisms. The aims are to provide new analytical methods needed for to determine the actual environmental exposure of these drugs, their metabolites and transformation products detection, to provide missing ecotoxicity data needed for accurate environmental risk assessment and identify biomarkers of delayed effects that may be used for development of early warning systems.
Keywords:health risks, cytostatics
Publication status:Published
Publication version:Version of Record
Publication date:31.12.2014
Place of publishing:[S. l.]
Place of performance:[S. l.]
Publisher:European commission, Research and innovation
Year of publishing:2014
Year of performance:2014
Number of pages:16 str.
PID:20.500.12556/DiRROS-20319 New window
UDC:614
COBISS.SI-ID:3075407 New window
Note:Projekt je trajal od 1. 7. 2012 do 31. 12. 2013; ǂProject no. ǂ265264;
Publication date in DiRROS:03.09.2024
Views:324
Downloads:190
Metadata:XML DC-XML DC-RDF
:
FILIPIČ, Metka, 2014, Fate and effects of cytostatic pharmaceuticals in the environment and the identification of biomarkers for and improved risk assessment on environmental exposure [online]. Treatise, Preliminary Study, Study. S. l. : European commission, Research and innovation. [Accessed 30 March 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=20319
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Document is financed by a project

Funder:Other - Other funder or multiple funders
Name:Specific Programme "Cooperation": Environment (including Climate Change)
Funder:Other - Other funder or multiple funders
Name:CytoThreat
Funder:Other - Other funder or multiple funders
Name:Globaqua
Funder:Other - Other funder or multiple funders
Name:Endetech
Funder:Other - Other funder or multiple funders
Name:SCARCE from the Consolider Programme

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back